Breaking
🌏 NMPA
Pfizer AI Strategy: Driving Pharma Innovation and Dominance
AnalysisApr 27, 2026

Pfizer AI Strategy: Driving Pharma Innovation and Dominance

Discover how Pfizer’s AI strategy is transforming pharmaceutical R&D, accelerating drug discovery, optimizing clinical trials, and reinforcing its leadership in the pharma industry, with a focus on the APAC region.

Dr. Laura Bennett
AI Drug Discovery Patent Rankings 2025: Deep EigenMatics Leads Globally
AnalysisApr 27, 2026

AI Drug Discovery Patent Rankings 2025: Deep EigenMatics Leads Globally

Deep EigenMatics has topped the 2025 AI drug discovery patent rankings, outpacing major pharma globally. Discover how AI is reshaping pharmaceutical innovation.

Dr. Natalie Hughes
AI-Driven Drug Discovery Partnership: Merck and Mayo Clinic Lead Innovation
AnalysisApr 27, 2026

AI-Driven Drug Discovery Partnership: Merck and Mayo Clinic Lead Innovation

Merck and the Mayo Clinic have launched a groundbreaking AI-driven drug discovery partnership. This collaboration aims to revolutionize pharmaceutical research by integrating artificial intelligence and clinical expertise to speed up new drug development.

Dr. Lukas Schneider
Pharma Supercomputer: Eli Lilly and NVIDIA’s AI-Powered Breakthrough
AnalysisApr 27, 2026

Pharma Supercomputer: Eli Lilly and NVIDIA’s AI-Powered Breakthrough

Eli Lilly and NVIDIA have partnered to build the pharmaceutical industry's most powerful supercomputer. This AI-driven innovation aims to accelerate drug discovery and development, enhancing computational research capabilities globally.

Matteo Ricci
Merck Mayo Clinic AI Partnership: Advancing Drug Discovery
AnalysisApr 27, 2026

Merck Mayo Clinic AI Partnership: Advancing Drug Discovery

Merck and the Mayo Clinic have joined forces to leverage AI in accelerating drug discovery and development. This partnership combines Merck's expertise with Mayo Clinic's research capabilities to transform pharmaceutical innovation.

Michael Rivera
Sanyou AI-STAL 2.0 Reduces Antibody Discovery Time from Months to 14 Days in Drug Development Breakthrough
NewsDrug Discovery Platform TechnologyApr 16, 2026

Sanyou AI-STAL 2.0 Reduces Antibody Discovery Time from Months to 14 Days in Drug Development Breakthrough

Sanyou's AI-STAL 2.0 platform revolutionizes drug discovery by reducing antibody development timelines from months to just 14 days, transforming pharmaceutical R&D.

Dr. Yuki Tanaka
Peer AI Launches Advanced Regulatory Platform with Predictive Intelligence for Life Sciences Submissions
NewsApr 15, 2026

Peer AI Launches Advanced Regulatory Platform with Predictive Intelligence for Life Sciences Submissions

Peer AI expands its agentic AI platform for life sciences with real-time visibility and predictive regulatory query capabilities to streamline drug submissions.

Dr. Yuki Tanaka